CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Grant or award EVP, Chief Financial Officer acquired 11,534 shares (grant or award)
- 4 Shares withheld for taxes EVP, Chief HR Officer gave up 237 shares (to pay taxes)
- 4 Grant or award President and COO acquired 1,293 shares (grant or award)
- 4 Open-market sale Director sold 7,893 shares at $55.00 ($434,115)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chairman gave up 3,224 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Administration and CFO gave up 1,727 shares (to pay taxes)
- 4 Open-market sale EVP, Business Operations sold 5,842 shares at $52.82 ($308,574)
- 4 Shares withheld for taxes President & CEO gave up 7,825 shares (to pay taxes)
- 4 Exercise or conversion EVP, Business Operations acquired 6,573 shares (option exercise)
- 4 Shares withheld for taxes Chairman gave up 4,753 shares (to pay taxes)
- 4 Grant or award EVP, Corp Dev, GC & Secretary acquired 10,626 shares (grant or award)
- 4 Shares withheld for taxes EVP, Chief HR Officer gave up 927 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Administration and CFO gave up 2,323 shares (to pay taxes)
- 4 Open-market sale EVP, Business Operations sold 1,898 shares at $49.50 ($93,951)
- 4 Shares withheld for taxes President & CEO gave up 9,923 shares (to pay taxes)
- 4 Open-market sale Director sold 7,729 shares at an average $50.69 ($391,787)
- 4 Open-market sale President & CEO sold 21,906 shares at $47.91 ($1,049,516)
- 4 Open-market sale President & CEO sold 20,000 shares at $45.99 ($919,800)
- 4 Open-market sale Director sold 23,681 shares at $45.02 ($1,066,225)
Page 20 of 49 · 970 filings